obicoxib

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nameobicoxib
Drug Alias NameCOX 2 inhibitor (Tianjin Institute of Pharmaceutical Research)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Pharmaceutical Research Institute Of The State Drug Administration
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Pharmaceutical Research Institute Of The State Drug Administration
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A